The prices listed in the CMS release reflect hospitals’ pre-negotiated prices, which hospitals typically discount heavily when contracting with payors, Moody’s Assistant Vice President and Analyst Daniel Steingart said in the report.
“[However,] there is substantial risk the persistence of unexplainable differences in hospital charges will invite greater regulation of the industry and supports our negative sector outlook,” Mr. Steingart said in the report. “Longer-term credit implications are negative for hospitals…especially those that are truly higher cost.”
Hospitals and health systems may begin making prices more transparent to customers as a marketing strategy, although the risk remains that regulators will look to intervene to balance out prices.
More Articles on Price Transparency:
UnitedHealthcare Unveils Price Transparency Tool
HHS Announces $1B for Second Round of Health Care Innovation Awards
CEO of Florida’s Mount Sinai Challenges Competitors to Post Prices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit